Clinical Trial Detail

NCT ID NCT04261218
Title Safety, Pharmacodynamics, Pharmacokinetics, and Efficacy of Tomivosertib Combined With Paclitaxel in Advanced Breast Cancer
Recruitment Not yet recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Translational Research in Oncology
Indications

breast adenocarcinoma

Therapies

Paclitaxel + Tomivosertib

Age Groups: adult senior

No variant requirements are available.